These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33649199)

  • 1. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
    Tengesdal IW; Menon DR; Osborne DG; Neff CP; Powers NE; Gamboni F; Mauro AG; D'Alessandro A; Stefanoni D; Henen MA; Mills TS; De Graaf DM; Azam T; Vogeli B; Palmer BE; Pietras EM; DeGregori J; Tan AC; Joosten LAB; Fujita M; Dinarello CA; Marchetti C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression.
    Tengesdal IW; Dinarello A; Powers NE; Burchill MA; Joosten LAB; Marchetti C; Dinarello CA
    Front Immunol; 2021; 12():661323. PubMed ID: 34531850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells.
    Lee HE; Lee JY; Yang G; Kang HC; Cho YY; Lee HS; Lee JY
    Sci Rep; 2019 Aug; 9(1):12277. PubMed ID: 31439870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.
    van Deventer HW; Burgents JE; Wu QP; Woodford RM; Brickey WJ; Allen IC; McElvania-Tekippe E; Serody JS; Ting JP
    Cancer Res; 2010 Dec; 70(24):10161-9. PubMed ID: 21159638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.
    Theivanthiran B; Evans KS; DeVito NC; Plebanek M; Sturdivant M; Wachsmuth LP; Salama AK; Kang Y; Hsu D; Balko JM; Johnson DB; Starr M; Nixon AB; Holtzhausen A; Hanks BA
    J Clin Invest; 2020 May; 130(5):2570-2586. PubMed ID: 32017708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.
    Chen L; Huang CF; Li YC; Deng WW; Mao L; Wu L; Zhang WF; Zhang L; Sun ZJ
    Cell Mol Life Sci; 2018 Jun; 75(11):2045-2058. PubMed ID: 29184980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1β mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer.
    Zhang Z; Chen Y; Pan X; Li P; Ren Z; Wang X; Chen Y; Shen S; Wang T; Lin A
    Cell Commun Signal; 2024 Aug; 22(1):408. PubMed ID: 39164774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.
    Koehn BH; Saha A; McDonald-Hyman C; Loschi M; Thangavelu G; Ma L; Zaiken M; Dysthe J; Krepps W; Panthera J; Hippen K; Jameson SC; Miller JS; Cooper MA; Farady CJ; Iwawaki T; Ting JP; Serody JS; Murphy WJ; Hill GR; Murray PJ; Bronte V; Munn DH; Zeiser R; Blazar BR
    Blood; 2019 Nov; 134(19):1670-1682. PubMed ID: 31533918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of NLRP3 inflammasome by lymphocytic microparticles via TLR4 pathway contributes to airway inflammation.
    Qiu Q; Yang Z; Cao F; Yang C; Hardy P; Yan X; Yang S; Xiong W
    Exp Cell Res; 2020 Jan; 386(2):111737. PubMed ID: 31759058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes.
    Ballbach M; Hall T; Brand A; Neri D; Singh A; Schaefer I; Herrmann E; Hansmann S; Handgretinger R; Kuemmerle-Deschner J; Hartl D; Rieber N
    J Innate Immun; 2016; 8(5):493-506. PubMed ID: 27351923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.
    Segovia JA; Chang TH; Winter VT; Coalson JJ; Cagle MP; Pandranki L; Bose S; Baseman JB; Kannan TR
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061706
    [No Abstract]   [Full Text] [Related]  

  • 12. MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes.
    Zhu Y; Chen P; Hu B; Zhong S; Yan K; Wu Y; Li S; Yang Y; Xu Z; Lu Y; Ouyang Y; Bao H; Gu W; Wen L; Zhang Y
    Biomaterials; 2024 Jun; 307():122533. PubMed ID: 38493671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RORγ regulates the NLRP3 inflammasome.
    Billon C; Murray MH; Avdagic A; Burris TP
    J Biol Chem; 2019 Jan; 294(1):10-19. PubMed ID: 30455347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-27 regulates NLRP3 inflammasome activation of MDSCs in experimental Sjögren's syndrome.
    Xia X; Long Q; Zha J; Jiang T; Guo J; Jiang B; Li X; Yao G
    Int Immunol; 2023 Nov; 35(11):531-542. PubMed ID: 37756640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NS1 Protein of 2009 Pandemic Influenza A Virus Inhibits Porcine NLRP3 Inflammasome-Mediated Interleukin-1 Beta Production by Suppressing ASC Ubiquitination.
    Park HS; Liu G; Thulasi Raman SN; Landreth SL; Liu Q; Zhou Y
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.
    Mohamed E; Sierra RA; Trillo-Tinoco J; Cao Y; Innamarato P; Payne KK; de Mingo Pulido A; Mandula J; Zhang S; Thevenot P; Biswas S; Abdalla SK; Costich TL; Hänggi K; Anadon CM; Flores ER; Haura EB; Mehrotra S; Pilon-Thomas S; Ruffell B; Munn DH; Cubillos-Ruiz JR; Conejo-Garcia JR; Rodriguez PC
    Immunity; 2020 Apr; 52(4):668-682.e7. PubMed ID: 32294407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
    Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
    Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 Inflammasome and Caspase-1/11 Pathway Orchestrate Different Outcomes in the Host Protection Against
    Paroli AF; Gonzalez PV; Díaz-Luján C; Onofrio LI; Arocena A; Cano RC; Carrera-Silva EA; Gea S
    Front Immunol; 2018; 9():913. PubMed ID: 29774028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical NLRP3 inflammasome activation and IL-1β signaling are necessary to L. amazonensis control mediated by P2X7 receptor and leukotriene B4.
    Chaves MM; Sinflorio DA; Thorstenberg ML; Martins MDA; Moreira-Souza ACA; Rangel TP; Silva CLM; Bellio M; Canetti C; Coutinho-Silva R
    PLoS Pathog; 2019 Jun; 15(6):e1007887. PubMed ID: 31233552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell.
    Yao M; Fan X; Yuan B; Takagi N; Liu S; Han X; Ren J; Liu J
    BMC Complement Altern Med; 2019 Aug; 19(1):216. PubMed ID: 31412862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.